Tracheobronchial protease inhibitors, body surface area burns, and mortality in smoke inhalation

Margaret Kurzius-Spencer, Kevin Foster, Sally Littau, Karen J. Richey, Beth M. Clark, Duane L Sherrill, Scott A Boitano, Daniel M. Caruso, Jefferey L Burgess

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The objective of this study was to assess tracheobronchial protease inhibitor concentrations longitudinally and determine whether initial concentrations predict subsequent lung injury and mortality in intubated burn victims. Tracheobronchial suction fluid was collected every 2 hours for 36 hours. Alpha-1-antitrypsin (AAT), secretory leukocyte peptidase inhibitor (SLPI), alpha-2-macroglobulin (A2M), and cell and differential counts were assayed. Partial pressure of oxygen in arterial blood/fraction of inspired oxygen (PaO2/FIO2) and peak airway pressure (PAP) were recorded for 72 hours. Standard statistics were used to evaluate cross-sectional relationships; random coefficient (mixed) models were used to evaluate temporal trends in marker concentrations and relation to clinical outcomes. Among 29 patients, 24 (83%) developed hypoxemia (PaO2/FIO2 <200); six died within 2 weeks. When adjusted for gender, age, %TBSA burn, and positive end-expiratory pressure setting, A2M (P ≤ .007) and neutrophils (P ≤ .032) increased linearly during 36 hours, and SLPI decreased (P ≤ .038). Initial SLPI concentration was a negative predictor of maximum PAP (P ≤ .009). None of the markers predicted longitudinal change in PaO2/FIO2. Mean levels of AAT and A2M in initial samples were significantly lower in patients with >35% TBSA burn (P ≤ .010 and .033, respectively), when compared with patients with less severe burns. However, patients with increased A2M in combination with >35% TBSA burn had a 6-fold (95% CI: 1.8ĝ€"20) increased relative risk of death. Tracheobronchial AAT and A2M levels were significantly lower in patients with more severe burns and increased over time. Initial SLPI levels predicted subsequent PAP. Increased early A2M in combination with extensive burn predicted early mortality.

Original languageEnglish (US)
Pages (from-to)824-831
Number of pages8
JournalJournal of Burn Care and Research
Volume30
Issue number5
DOIs
StatePublished - Sep 2009

Fingerprint

alpha-Macroglobulins
Body Surface Area
Protease Inhibitors
Burns
Smoke
Inhalation
Secretory Leukocyte Peptidase Inhibitor
alpha 1-Antitrypsin
Mortality
Oxygen
Pressure
Partial Pressure
Suction
Lung Injury
Cell Count

ASJC Scopus subject areas

  • Emergency Medicine
  • Rehabilitation
  • Surgery

Cite this

Tracheobronchial protease inhibitors, body surface area burns, and mortality in smoke inhalation. / Kurzius-Spencer, Margaret; Foster, Kevin; Littau, Sally; Richey, Karen J.; Clark, Beth M.; Sherrill, Duane L; Boitano, Scott A; Caruso, Daniel M.; Burgess, Jefferey L.

In: Journal of Burn Care and Research, Vol. 30, No. 5, 09.2009, p. 824-831.

Research output: Contribution to journalArticle

@article{115f76f2a1794b32ae058a4ca19290f2,
title = "Tracheobronchial protease inhibitors, body surface area burns, and mortality in smoke inhalation",
abstract = "The objective of this study was to assess tracheobronchial protease inhibitor concentrations longitudinally and determine whether initial concentrations predict subsequent lung injury and mortality in intubated burn victims. Tracheobronchial suction fluid was collected every 2 hours for 36 hours. Alpha-1-antitrypsin (AAT), secretory leukocyte peptidase inhibitor (SLPI), alpha-2-macroglobulin (A2M), and cell and differential counts were assayed. Partial pressure of oxygen in arterial blood/fraction of inspired oxygen (PaO2/FIO2) and peak airway pressure (PAP) were recorded for 72 hours. Standard statistics were used to evaluate cross-sectional relationships; random coefficient (mixed) models were used to evaluate temporal trends in marker concentrations and relation to clinical outcomes. Among 29 patients, 24 (83{\%}) developed hypoxemia (PaO2/FIO2 <200); six died within 2 weeks. When adjusted for gender, age, {\%}TBSA burn, and positive end-expiratory pressure setting, A2M (P ≤ .007) and neutrophils (P ≤ .032) increased linearly during 36 hours, and SLPI decreased (P ≤ .038). Initial SLPI concentration was a negative predictor of maximum PAP (P ≤ .009). None of the markers predicted longitudinal change in PaO2/FIO2. Mean levels of AAT and A2M in initial samples were significantly lower in patients with >35{\%} TBSA burn (P ≤ .010 and .033, respectively), when compared with patients with less severe burns. However, patients with increased A2M in combination with >35{\%} TBSA burn had a 6-fold (95{\%} CI: 1.8ĝ€{"}20) increased relative risk of death. Tracheobronchial AAT and A2M levels were significantly lower in patients with more severe burns and increased over time. Initial SLPI levels predicted subsequent PAP. Increased early A2M in combination with extensive burn predicted early mortality.",
author = "Margaret Kurzius-Spencer and Kevin Foster and Sally Littau and Richey, {Karen J.} and Clark, {Beth M.} and Sherrill, {Duane L} and Boitano, {Scott A} and Caruso, {Daniel M.} and Burgess, {Jefferey L}",
year = "2009",
month = "9",
doi = "10.1097/BCR.0b013e3181b47ee8",
language = "English (US)",
volume = "30",
pages = "824--831",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Tracheobronchial protease inhibitors, body surface area burns, and mortality in smoke inhalation

AU - Kurzius-Spencer, Margaret

AU - Foster, Kevin

AU - Littau, Sally

AU - Richey, Karen J.

AU - Clark, Beth M.

AU - Sherrill, Duane L

AU - Boitano, Scott A

AU - Caruso, Daniel M.

AU - Burgess, Jefferey L

PY - 2009/9

Y1 - 2009/9

N2 - The objective of this study was to assess tracheobronchial protease inhibitor concentrations longitudinally and determine whether initial concentrations predict subsequent lung injury and mortality in intubated burn victims. Tracheobronchial suction fluid was collected every 2 hours for 36 hours. Alpha-1-antitrypsin (AAT), secretory leukocyte peptidase inhibitor (SLPI), alpha-2-macroglobulin (A2M), and cell and differential counts were assayed. Partial pressure of oxygen in arterial blood/fraction of inspired oxygen (PaO2/FIO2) and peak airway pressure (PAP) were recorded for 72 hours. Standard statistics were used to evaluate cross-sectional relationships; random coefficient (mixed) models were used to evaluate temporal trends in marker concentrations and relation to clinical outcomes. Among 29 patients, 24 (83%) developed hypoxemia (PaO2/FIO2 <200); six died within 2 weeks. When adjusted for gender, age, %TBSA burn, and positive end-expiratory pressure setting, A2M (P ≤ .007) and neutrophils (P ≤ .032) increased linearly during 36 hours, and SLPI decreased (P ≤ .038). Initial SLPI concentration was a negative predictor of maximum PAP (P ≤ .009). None of the markers predicted longitudinal change in PaO2/FIO2. Mean levels of AAT and A2M in initial samples were significantly lower in patients with >35% TBSA burn (P ≤ .010 and .033, respectively), when compared with patients with less severe burns. However, patients with increased A2M in combination with >35% TBSA burn had a 6-fold (95% CI: 1.8ĝ€"20) increased relative risk of death. Tracheobronchial AAT and A2M levels were significantly lower in patients with more severe burns and increased over time. Initial SLPI levels predicted subsequent PAP. Increased early A2M in combination with extensive burn predicted early mortality.

AB - The objective of this study was to assess tracheobronchial protease inhibitor concentrations longitudinally and determine whether initial concentrations predict subsequent lung injury and mortality in intubated burn victims. Tracheobronchial suction fluid was collected every 2 hours for 36 hours. Alpha-1-antitrypsin (AAT), secretory leukocyte peptidase inhibitor (SLPI), alpha-2-macroglobulin (A2M), and cell and differential counts were assayed. Partial pressure of oxygen in arterial blood/fraction of inspired oxygen (PaO2/FIO2) and peak airway pressure (PAP) were recorded for 72 hours. Standard statistics were used to evaluate cross-sectional relationships; random coefficient (mixed) models were used to evaluate temporal trends in marker concentrations and relation to clinical outcomes. Among 29 patients, 24 (83%) developed hypoxemia (PaO2/FIO2 <200); six died within 2 weeks. When adjusted for gender, age, %TBSA burn, and positive end-expiratory pressure setting, A2M (P ≤ .007) and neutrophils (P ≤ .032) increased linearly during 36 hours, and SLPI decreased (P ≤ .038). Initial SLPI concentration was a negative predictor of maximum PAP (P ≤ .009). None of the markers predicted longitudinal change in PaO2/FIO2. Mean levels of AAT and A2M in initial samples were significantly lower in patients with >35% TBSA burn (P ≤ .010 and .033, respectively), when compared with patients with less severe burns. However, patients with increased A2M in combination with >35% TBSA burn had a 6-fold (95% CI: 1.8ĝ€"20) increased relative risk of death. Tracheobronchial AAT and A2M levels were significantly lower in patients with more severe burns and increased over time. Initial SLPI levels predicted subsequent PAP. Increased early A2M in combination with extensive burn predicted early mortality.

UR - http://www.scopus.com/inward/record.url?scp=70349658522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349658522&partnerID=8YFLogxK

U2 - 10.1097/BCR.0b013e3181b47ee8

DO - 10.1097/BCR.0b013e3181b47ee8

M3 - Article

C2 - 19692916

AN - SCOPUS:70349658522

VL - 30

SP - 824

EP - 831

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 5

ER -